Treatment with analgesics after mouse sciatic nerve injury does not alter expression of wound healing-associated genes.
Vance P LemmonDario MottiDonna L AvisonJohn L BixbyVance P LemmonPublished in: Neural regeneration research (2016)
Animal models of sciatic nerve injury are commonly used to study neuropathic pain as well as axon regeneration. Administration of post-surgical analgesics is an important consideration for animal welfare, but the actions of the analgesic must not interfere with the scientific goals of the experiment. In this study, we show that treatment with either buprenorphine or acetaminophen following a bilateral sciatic nerve crush surgery does not alter the expression in dorsal root ganglion (DRG) sensory neurons of a panel of genes associated with wound healing. These findings indicate that the post-operative use of buprenorphine or acetaminophen at doses commonly suggested by Institutional Animal Care and Use Committees does not change the intrinsic gene expression response of DRG neurons to a sciatic nerve crush injury, for many wound healing-associated genes. Therefore, administration of post-operative analgesics may not confound the results of transcriptomic studies employing this injury model.
Keyphrases
- neuropathic pain
- wound healing
- spinal cord
- gene expression
- spinal cord injury
- poor prognosis
- optic nerve
- minimally invasive
- palliative care
- single cell
- long non coding rna
- coronary artery disease
- acute coronary syndrome
- rna seq
- quality improvement
- case report
- pain management
- genome wide identification
- bioinformatics analysis
- public health
- transcription factor
- smoking cessation